| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $303K | — | — |
| SG&A Expense | $1.3M | — | +43.6% |
| Operating Income | -$1.6M | — | -75.9% |
| Pre-tax Income | -$164.0M | — | — |
| Income Tax | $31K | — | -26.2% |
| Net Income | -$164.1M | — | — |
| EPS (Basic) | -$2.53 | — | -3062.5% |
| EPS (Diluted) | -$2.53 | — | -3062.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17K | -96.3% | -67.2% |
| Current Assets | $207K | -75.1% | +171.9% |
| Total Assets | $506.7M | -24.4% | — |
| Current Liabilities | $1.9M | +57.6% | +21.8% |
| Total Liabilities | $2.6M | +30.4% | -1.4% |
| Stockholders' Equity | $503.8M | -24.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$649K | — | +21.9% |
| Investing Cash Flow | -$100K | — | — |
| Financing Cash Flow | $310K | — | -64.0% |
| — |